![]() |
OpGenOpGen is commercializing a novel single molecule DNA analysis technology, "Optical Mapping", for rapid identification and analysis of microorganisms. The system can be used to obtain detailed genetic information with no requirement for prior sequence data, PCR, cloning, or probes. Applications of the new commercial systems include clinical microbial analysis, forensic microbiology and the development of novel molecular diagnostic products. Recent NewsOpGen’s Strategic Investment With In-Q-Tel Yields Commercial Availability of Optical Mapping InstrumentOpGen Announces Strategic Investment and Technology Advancement Agreement with In-Q-TelOpGen Announces $23.6 Million Series A Financing |
![]() CEOEvan JonesContact Info708 Quince Orchard Rd.Gaithersburg, Maryland 20878 Phone: 301.869.9683 Fax: 301.869.9684 Key LinksWebsiteJobs Info Highland Team Corey Mulloy
Bijan Salehizadeh, M.D.
|